IIM
OBIO icon

INTECH Investment Management’s Orchestra BioMed OBIO Stock Holding History

INTECH Investment Management’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,002
Closed -$68.5K – 2606
2025
Q1 		$68.5K Buy
16,002
+5,511
+53% +$27.4K ﹤0.01% 2392
2024
Q4 		$42K Buy
+10,491
New +$56.4K ﹤0.01% 2347

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

INTECH Investment Management's OBIO Position: Q2 2025 in Review

INTECH Investment Management sold out of Orchestra BioMed (OBIO) in Q2 2025, closing a stake of 16,002 shares — an estimated $68.5K sold.

INTECH Investment Management first reported a position in OBIO in Q4 2024 and held it in 2 quarters. The position peaked at $68.5K in Q1 2025. 59 funds tracked by Wall St. Rank hold OBIO as of Q2 2025.

  • INTECH Investment Management reported no remaining Orchestra BioMed position as of Q2 2025 after selling out during the quarter.
  • INTECH Investment Management sold 16,002 Orchestra BioMed shares in Q2 2025, an estimated $68.5K.
  • INTECH Investment Management first reported a position in Orchestra BioMed in Q4 2024 and held it in 2 quarters.
  • INTECH Investment Management's Orchestra BioMed position peaked at $68.5K in Q1 2025.
  • 59 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2025.

Based on INTECH Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.